Exemestane Tablets | Aromatase Inhibitor for Estrogen Reduction | Superior Health & Wellness
Exemestane Tablets | Aromatase Inhibitor for Estrogen Reduction | Superior Health & Wellness

Exemestane Tablets | Aromatase Inhibitor for Estrogen Reduction

$0.00

Exemestane tablets are an FDA-approved oral aromatase inhibitor that may be prescribed as part of a personalized men’s hormone optimization program when clinically appropriate. While Exemestane is FDA approved for the treatment of certain types of hormone receptor-positive breast cancer in postmenopausal women, licensed healthcare providers may prescribe it off-label for men receiving testosterone replacement therapy (TRT) who develop elevated estrogen levels.

Testosterone can naturally convert into estrogen through the aromatase enzyme. In some men, increased estrogen levels may contribute to symptoms such as breast tenderness or enlargement (gynecomastia), fluid retention, mood changes, or difficulty achieving optimal hormone balance. By reducing the conversion of testosterone into estrogen, Exemestane may help support a more balanced hormonal profile when prescribed as part of an individualized treatment plan.

Not every patient receiving testosterone therapy requires an aromatase inhibitor. Superior providers determine whether Exemestane is clinically appropriate based on your symptoms, laboratory results, medical history, and ongoing monitoring. Treatment should only be taken exactly as prescribed by your licensed healthcare provider

This medication is an FDA-approved commercial product dispensed by a licensed pharmacy. Review important medication safety information.

Pricing is provided for reference only. All medications require a valid prescription from a Superior provider and are dispensed directly by our partnering pharmacies — not sold through this website.

Product: Price, Dose, Estimated Supply, Info Requests:

Exemestane tablets are an FDA-approved oral aromatase inhibitor that may be prescribed as part of a personalized men’s hormone optimization program when clinically appropriate. While Exemestane is FDA approved for the treatment of certain types of hormone receptor-positive breast cancer in postmenopausal women, licensed healthcare providers may prescribe it off-label for men receiving testosterone replacement therapy (TRT) who develop elevated estrogen levels.

Testosterone can naturally convert into estrogen through the aromatase enzyme. In some men, increased estrogen levels may contribute to symptoms such as breast tenderness or enlargement (gynecomastia), fluid retention, mood changes, or difficulty achieving optimal hormone balance. By reducing the conversion of testosterone into estrogen, Exemestane may help support a more balanced hormonal profile when prescribed as part of an individualized treatment plan.

Not every patient receiving testosterone therapy requires an aromatase inhibitor. Superior providers determine whether Exemestane is clinically appropriate based on your symptoms, laboratory results, medical history, and ongoing monitoring. Treatment should only be taken exactly as prescribed by your licensed healthcare provider

This medication is an FDA-approved commercial product dispensed by a licensed pharmacy. Review important medication safety information.

Pricing is provided for reference only. All medications require a valid prescription from a Superior provider and are dispensed directly by our partnering pharmacies — not sold through this website.

The availability of specific medication types may vary and is subject to pharmacy supply.

    1. Tablets

  • • Lowers estrogen production in postmenopausal women

    • Helps reduce the risk of breast cancer recurrence after tamoxifen therapy

    • May slow progression of advanced estrogen receptor positive breast cancer

    • Provides a targeted hormonal approach as part of a comprehensive oncology treatment plan

  • Common side effects may include:

    • Hot flashes

    • Fatigue

    • Joint pain or stiffness

    • Headache

    • Insomnia

    • Increased sweating

    • Nausea

    • Increased appetite

    Serious side effects require immediate medical attention and may include:

    • Chest pain or symptoms of heart attack

    • Shortness of breath

    • Signs of blood clots

    • Severe allergic reactions such as rash, swelling, or difficulty breathing

    • Yellowing of the skin or eyes indicating possible liver problems

    • Severe bone pain or fractures

    Exemestane may reduce bone mineral density over time, increasing the risk of osteoporosis and fractures. Bone health monitoring may be recommended.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

  • Exemestane is indicated only for postmenopausal women with specific types of breast cancer. It should not be used in premenopausal women.

    Do not take exemestane if you:

    • Are pregnant or may become pregnant

    • Have a known hypersensitivity to exemestane or any of its ingredients

    Exemestane can cause fetal harm. Females of reproductive potential should use effective contraception during treatment and for 1 month after the final dose. Do not breastfeed during treatment and for 1 month after the last dose.

    Tell your provider if you have osteoporosis, low vitamin D levels, liver or kidney problems, cardiovascular disease, or if you take estrogen containing medications. Certain medications that strongly induce CYP3A4 may reduce exemestane levels and require dose adjustments.

    Regular monitoring may include assessment of bone mineral density, liver function, and overall cardiovascular health. Use only as prescribed and do not combine with estrogen containing therapies unless directed by your provider.

Medical Disclaimer: This summary does not include all information about Exemestane Tablets and does not replace medical advice. Always consult your healthcare provider or pharmacist for complete safety information, potential interactions, and individualized recommendations. All prescriptions are based on individual lab results and are provided only at the discretion of a licensed provider. Results may vary. Treatment outcomes depend on individual patient health, labs, and provider recommendations. These statements have not been evaluated by the FDA. Product images are for mock-up and branding purposes only. Actual medications and packaging may vary based on pharmacy fulfillment.